Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06795360
NA
Weight Changes After Incretin-mimetics
Sponsor: Medical College of Wisconsin
View on ClinicalTrials.gov
Summary
The goal of this study is to identify people at risk of weight regain after stopping an injectable weight loss drug. The main question the investigators aim to answer is: Can weight regain be predicted by measuring circulating Agouti-related peptide, a small protein coming from the brain?
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2026-12-01
Completion Date
2031-11-30
Last Updated
2026-02-24
Healthy Volunteers
No
Interventions
OTHER
discontinuation of weight loss medication
Participants will be studied right before their injectable weight loss medication runs out, and 3 months later